Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1318420 | Peak area | BS4 | Untreated |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1419414 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1443240 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1457160 | Peak area | BS4 | IL-17A |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1468281 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1478275 | Peak area | PAK | IL-17A |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1489197 | Peak area | HAHA | TNF-alpha |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1503682 | Peak area | HAHA | IL-17A |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1526741 | Peak area | BS4 | TNF-alpha |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1571950 | Peak area | PAK | TNF-alpha |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1579577 | Peak area | PAK | Untreated |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1711727 | Peak area | HAHA | IFN-G |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1714441 | Peak area | PAK | IFN-G |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1949997 | Peak area | BS4 | IFN-G |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1966261 | Peak area | HAHA | Untreated |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2170280 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2188415 | Peak area | BS4 | Untreated |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2190551 | Peak area | HAHA | TNF-alpha |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2228585 | Peak area | HAHA | IL-17A |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2259069 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2305575 | Peak area | PAK | TNF-alpha |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2327450 | Peak area | BS4 | IL-17A |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2385789 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2493975 | Peak area | HAHA | IFN-G |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2517214 | Peak area | BS4 | TNF-alpha |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2527644 | Peak area | PAK | IL-17A |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2560915 | Peak area | PAK | Untreated |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2700951 | Peak area | PAK | IFN-G |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2884312 | Peak area | BS4 | IFN-G |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2998979 | Peak area | HAHA | Untreated |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+ | 1759280 | Peak area | BS4 | IL-17A |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+ | 4400587 | Peak area | PAK | IL-17A |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+ | 4413215 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+ | 5380901 | Peak area | HAHA | TNF-alpha |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+ | 5396116 | Peak area | PAK | TNF-alpha |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+ | 5413091 | Peak area | HAHA | IFN-G |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+ | 5540730 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+ | 5781374 | Peak area | BS4 | Untreated |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+ | 5783493 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+ | 5836791 | Peak area | HAHA | IL-17A |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+ | 5861981 | Peak area | PAK | Untreated |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+ | 6025213 | Peak area | BS4 | TNF-alpha |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+ | 6207770 | Peak area | PAK | IFN-G |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+ | 6268148 | Peak area | BS4 | IFN-G |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+ | 7179219 | Peak area | HAHA | Untreated |